Premier Alternatives

Colossal Biosciences

Austin, TX · Founded 2021 · Privately Held (backing)

Operator of a bioscience and genetic engineering company developing technologies to advance genomics. Colossal Biosciences is based in Austin, TX and was founded in 2021. It was valued at $10.3 billion at its later-stage round in Sep 2025, the last priced event on record. It has raised $558 million across 1 recorded round; the latest was a $163 million later-stage round in Jan 2023.

PMV mark · valuation
$10.3B
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$557.6M
Last round
Later Stage VC
Jan 2023

Colossal Biosciences key facts

as of Oct 2026
  • Operator of a bioscience and genetic engineering company developing technologies to advance genomics.
  • Colossal Biosciences is valued at approximately $10.3B as of Oct 2026, set at its later-stage round, Sep 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $557.6M across 1 recorded rounds; the latest was Later Stage VC ($162.6M) in Jan 2023.
  • Notable investors include Climate Capital, Gaingels, Liquid 2 Ventures, Capital Factory, Calm Ventures — 51 tracked in total.
  • Colossal Biosciences has filed 2 Form Ds with the SEC since 2023, most recently Jul 2024 ($162.6M sold to 27 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$10.3B

Valued at $10.3B at its later-stage round, Sep 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Colossal Biosciences with a free account
  • ·The complete investor list: 51 names
  • ·Watch Colossal Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Colossal Biosciences funding rounds

1 rounds
Jan 2023Later Stage VC$162.6MSEC filing▮
Full funding history →

Colossal Biosciences valuation

Colossal Biosciences was valued at $10.3 billion at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Colossal Biosciences raised?

Colossal Biosciences has raised $558 million in total; 1 of its rounds is on record. The largest on record was a $163 million later-stage round in Jan 2023.

Colossal Biosciences has filed 2 Form Ds with the SEC since 2023, most recently in Jul 2024 ($163 million sold to 27 investors).

Colossal Biosciences investors

51 investors are on record for Colossal Biosciences, including Climate Capital, Gaingels, Liquid 2 Ventures and Capital Factory. By type, the record holds 22 venture capital firms and 1 angel investor. The later-stage round in Jan 2023 drew 27 investors.

About Colossal Biosciences

Operator of a bioscience and genetic engineering company developing technologies to advance genomics. The company applies gene-editing and CRISPR technologies to projects such as extinct species restoration, protection of critically endangered species, and the restoration of ecosystems, enabling environmental organizations to support biodiversity and ecosystem health.

Sector
Healthcare
HQ
Austin, TX, United States
Founded
2021
Employees
193
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.